Edwards Lifesciences Pre-Tax Profit Margin 2010-2024 | EW
Current and historical pre-tax profit margin for Edwards Lifesciences (EW) from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Edwards Lifesciences pre-tax profit margin for the three months ending June 30, 2024 was .
| Edwards Lifesciences Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2024-06-30 | $6.23B | $1.72B | 27.59% |
| 2024-03-31 | $6.14B | $1.61B | 26.17% |
| 2023-12-31 | $6.01B | $1.60B | 26.61% |
| 2023-09-30 | $5.59B | $1.57B | 28.15% |
| 2023-06-30 | $5.42B | $1.54B | 28.40% |
| 2023-03-31 | $5.50B | $1.73B | 31.45% |
| 2022-12-31 | $5.38B | $1.77B | 32.83% |
| 2022-09-30 | $5.36B | $1.68B | 31.39% |
| 2022-06-30 | $5.36B | $1.67B | 31.15% |
| 2022-03-31 | $5.36B | $1.75B | 32.65% |
| 2021-12-31 | $5.23B | $1.70B | 32.52% |
| 2021-09-30 | $5.10B | $1.68B | 33.01% |
| 2021-06-30 | $4.93B | $1.66B | 33.60% |
| 2021-03-31 | $4.48B | $0.94B | 21.03% |
| 2020-12-31 | $4.39B | $0.92B | 20.90% |
| 2020-09-30 | $4.37B | $0.88B | 20.07% |
| 2020-06-30 | $4.32B | $0.82B | 18.86% |
| 2020-03-31 | $4.48B | $1.25B | 27.97% |
| 2019-12-31 | $4.35B | $1.17B | 26.84% |
| 2019-09-30 | $4.15B | $0.85B | 20.45% |
| 2019-06-30 | $3.97B | $0.80B | 20.08% |
| 2019-03-31 | $3.82B | $0.78B | 20.30% |
| 2018-12-31 | $3.72B | $0.76B | 20.46% |
| 2018-09-30 | $3.64B | $1.09B | 29.93% |
| 2018-06-30 | $3.55B | $1.05B | 29.61% |
| 2018-03-31 | $3.45B | $1.01B | 29.18% |
| 2017-12-31 | $3.44B | $1.04B | 30.14% |
| 2017-09-30 | $3.32B | $0.91B | 27.50% |
| 2017-06-30 | $3.23B | $0.89B | 27.37% |
| 2017-03-31 | $3.15B | $0.85B | 26.92% |
| 2016-12-31 | $2.96B | $0.74B | 24.87% |
| 2016-09-30 | $2.87B | $0.70B | 24.56% |
| 2016-06-30 | $2.74B | $0.67B | 24.43% |
| 2016-03-31 | $2.60B | $0.64B | 24.72% |
| 2015-12-31 | $2.49B | $0.62B | 24.98% |
| 2015-09-30 | $2.44B | $0.59B | 24.13% |
| 2015-06-30 | $2.43B | $0.56B | 22.99% |
| 2015-03-31 | $2.39B | $1.23B | 51.46% |
| 2014-12-31 | $2.32B | $1.14B | 49.27% |
| 2014-09-30 | $2.24B | $1.11B | 49.60% |
| 2014-06-30 | $2.13B | $1.09B | 51.20% |
| 2014-03-31 | $2.07B | $0.40B | 19.22% |
| 2013-12-31 | $2.05B | $0.51B | 25.02% |
| 2013-09-30 | $2.02B | $0.53B | 26.29% |
| 2013-06-30 | $1.97B | $0.52B | 26.57% |
| 2013-03-31 | $1.94B | $0.49B | 25.45% |
| 2012-12-31 | $1.90B | $0.39B | 20.43% |
| 2012-09-30 | $1.82B | $0.34B | 18.58% |
| 2012-06-30 | $1.78B | $0.30B | 16.98% |
| 2012-03-31 | $1.73B | $0.29B | 16.50% |
| 2011-12-31 | $1.68B | $0.29B | 16.97% |
| 2011-09-30 | $1.64B | $0.29B | 17.43% |
| 2011-06-30 | $1.58B | $0.29B | 18.64% |
| 2011-03-31 | $1.51B | $0.29B | 18.99% |
| 2010-12-31 | $1.45B | $0.27B | 18.52% |
| 2010-09-30 | $1.40B | $0.26B | 18.54% |
| 2010-06-30 | $1.38B | $0.29B | 20.88% |
| 2010-03-31 | $1.35B | $0.29B | 21.11% |
| 2009-12-31 | $1.32B | $0.30B | 22.98% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $41.276B | $6.005B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $233.464B | 27.98 |
| Intuitive Surgical (ISRG) | United States | $174.074B | 98.56 |
| Alcon (ALC) | Switzerland | $48.585B | 34.20 |
| IQVIA Holdings (IQV) | United States | $43.515B | 24.66 |
| IDEXX Laboratories (IDXX) | United States | $41.198B | 49.56 |
| DexCom (DXCM) | United States | $27.855B | 39.72 |
| STERIS (STE) | Ireland | $24.144B | 28.17 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.386B | 0.00 |
| Waters (WAT) | United States | $19.344B | 28.84 |
| Hologic (HOLX) | United States | $18.849B | 20.49 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.376B | 13.88 |
| Sysmex ADR (SSMXY) | Japan | $12.361B | 38.76 |
| Teleflex (TFX) | United States | $11.593B | 18.03 |
| Globus Medical (GMED) | United States | $9.445B | 26.42 |
| Penumbra (PEN) | United States | $7.262B | 75.38 |
| Glaukos (GKOS) | United States | $6.939B | 0.00 |
| Masimo (MASI) | United States | $6.001B | 32.14 |
| TransMedics (TMDX) | United States | $5.051B | 216.31 |
| Integer Holdings (ITGR) | United States | $4.251B | 24.86 |
| PROCEPT BioRobotics (PRCT) | United States | $4.212B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.879B | 0.00 |
| Inari Medical (NARI) | United States | $2.711B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.635B | 15.46 |
| Veracyte (VCYT) | United States | $2.529B | 156.76 |
| Nihon Kohden (NHNKY) | Japan | $2.515B | 15.65 |
| Elekta AB (EKTAY) | Sweden | $2.461B | 20.05 |
| RxSight (RXST) | United States | $2.033B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.355B | 6.17 |
| Pulse Biosciences (PLSE) | United States | $1.134B | 0.00 |
| Silk Road Medical (SILK) | United States | $1.117B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.103B | 19.67 |
| OPKO Health (OPK) | United States | $1.095B | 0.00 |
| Artivion (AORT) | United States | $1.058B | 97.12 |
| Alphatec Holdings (ATEC) | United States | $0.785B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.782B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.680B | 17.17 |
| SiBone (SIBN) | United States | $0.656B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.640B | 0.00 |
| Paragon 28 (FNA) | United States | $0.617B | 0.00 |
| IRadimed (IRMD) | United States | $0.614B | 33.20 |
| AxoGen (AXGN) | United States | $0.604B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.493B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.350B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.347B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.329B | 10.04 |
| Treace Medical Concepts (TMCI) | United States | $0.318B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.308B | 0.00 |
| Inogen (INGN) | United States | $0.269B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.265B | 0.00 |
| Accuray (ARAY) | United States | $0.217B | 0.00 |
| NeuroPace (NPCE) | United States | $0.217B | 0.00 |
| Nevro (NVRO) | United States | $0.216B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.191B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.181B | 12.71 |
| CVRx (CVRX) | United States | $0.171B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.163B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.138B | 0.00 |
| 908 Devices (MASS) | United States | $0.125B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.120B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.115B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.104B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.100B | 14.85 |
| Hyperfine (HYPR) | United States | $0.076B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.072B | 0.00 |
| InspireMD (NSPR) | Israel | $0.068B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.068B | 0.00 |
| Envoy Medical (COCH) | United States | $0.064B | 0.00 |
| LENSAR (LNSR) | United States | $0.059B | 0.00 |
| Vaso (VASO) | United States | $0.055B | 14.75 |
| Covalon Technologies (CVALF) | Canada | $0.055B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.044B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.036B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.036B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.031B | 0.00 |
| ReWalk Robotics (LFWD) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| Spectral AI (MDAI) | United States | $0.023B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Neuronetics (STIM) | United States | $0.022B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.021B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.019B | 0.00 |
| PAVmed (PAVM) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.010B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.004B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |